South Wales, Nov. 21 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Bconnected" on Nov. 10. The details about the trademark application no. UK00004292295 published in the journal no. 2025/047 (Nov. 21).
With Abel & Imray LLP as representative, Novartis Pharma AG filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Electronic publications relating to breast cancer and the treatment thereof; downloadable applications for use in the management and treatment of breast cancer; downloadable applications for providing and tracking information relating to the management and treatment of breast cancer.
Class 41 : Educational and training services relating to breast cancer; educational services related to a patient support programme in the field of breast cancer; providing educational information in the field of breast cancer; conducting educational support programmes for patients and health care practitioners relating to breast cancer; training for patients and healthcare practitioners in the organisation of support groups for patients with breast cancer; conducting classes, seminars and workshops in the field of breast cancer; providing online non-downloadable publications in the nature of articles, books and journals in the field of breast cancer.
Class 44 : Medical and health care services relating to breast cancer; providing healthcare information to patients and health care practitioners in the field of breast cancer; providing medical information about breast cancer and the treatment thereof; providing medical support in the monitoring of patients receiving medical treatment for breast cancer; medical care and analysis services relating to the treatment of breast cancer.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004292295
Disclaimer: Curated by HT Syndication.
